Search Orphan Drug Designations and Approvals
-
Generic Name: | Fully human anti-galectin-9 IgG4 monoclonal antibody |
---|---|
Date Designated: | 02/27/2024 |
Orphan Designation: | Treatment of Acute Myeloid Leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
PureTech Health LLC 6 Tide Street, Suite 400 Boston, Massachusetts 02210 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-